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this arthritis model inflammation was increased in TLR2-/- mice.
In contrast, inflammation in TLR4-/- mice was decreased in the
arthritis model. However, in experimental OA in all strains, no
obvious differences in inflammation were found, so mechanisms
of action of TLR deficiencies in OA are probably unrelated to
inflammation.
Conclusions: In contrast to our expectations, these studies
indicate that both in TLR2 and TLR4 deficient mice OA pathology
is more severe when experimental OA is induced. This suggest
protective roles for both receptors in OA, in stead of the inducing
roles that were anticipated. The mechanisms via which TLR2 and
4 exert this effect remain unclear, although stimulation of TLR2
and 4 by endogenous ligands such as biglycan has been shown
to induce IL-10, TGFβ and HGF, which are protective mediators
for OA. The differences in preference for the joint compartment
may indicate different mechanisms, or differences in TLR2 and
4 distribution in the cartilage, but may also reflect strain related
differences. Although further research is needed, these results
indicate that during OA certain TLR pathways protect cartilage
from developing OA which may lead to clues for future therapy.
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NOVEL FUNCTIONS OF THE TIA-1 ARTHRITIS
SUPPRESSOR PROTEIN IN REGULATING TYPE II
PROCOLLAGEN GENE EXPRESSION
A. McAlinden, L. Liang, Y. Mukudai, T. Imamura, L.J. Sandell
Washington University, St Louis, MO
Purpose: One of the most important alternative splicing events
identified in connective tissue biology is the developmentally-
regulated processing of COL2A1. Here, exon 2, encoding a
cysteine-rich domain in the N-propeptide, is included in or ex-
cluded from mature mRNA producing type IIA (+ exon 2 in
chondroprogenitor cells) or type IIB procollagen (-exon 2 in dif-
ferentiated chondrocytes) (Fig.1A). We recently identified a novel
cis element in intron 2 of COL2A1 (Fig.1B) and proceeded to
investigate what trans-acting factors bind to this U-rich region.
We chose the arthritis suppressor RNA binding protein, TIA-1
(T-cell intracellular antigen 1), as a potential candidate as it has
been shown to regulate alternative splicing of other genes by
interacting with U-rich intronic sequences.
Methods: A COL2A1 mini-gene (Fig.1A) was co-transfected with
a TIA-1-encoding cDNA construct into different chondrocyte and
non-chondrocyte cells. RT-PCR of harvested mRNA was done
using primers specific for the COL2A1 mini-gene (Fig. 1A). IIA
and IIB cDNA isoforms were analyzed by phosphor-imaging.
TIA-1 was co-transfected with COL2A1 mini-genes containing
mutations in the T/U-rich region. Endogenous TIA-1 mRNA or
protein was analyzed by RT-PCR or Western blotting of nuclear
extracts. A GST/TIA-1 fusion protein was synthesized and used
in binding assays with radio-labelled RNA or DNA probes cor-
responding to the T/U-rich 38 nucleotide cis element (Fig.1B).
Electromobility shift or UV cross-linking assays were done to
detect protein/probe complexes in the presence or absence of
various competitors. Chromatin or RNA immunoprecipitation as-
says were done to confirm in vivo interaction of genomic DNA or
pre-mRNA with endogenous TIA-1 protein in the nucleus.
Results: TIA-1 regulated alternative splicing by increasing the
IIA mRNA isoform (+exon 2) in human chondrocytes and non-
chondrocytes. These cells also contained the highest levels of
endogenous TIA-1 compared to other cell types analyzed. Co-
transfection of TIA-1 with mutant COL2A1 mini-genes suggested
that the U-rich stretch (AUUUAUUUAUUU) was a potential TIA-1
RNA binding site. This was confirmed by RNA/protein binding
assays. GST/TIA-1 fusion protein interacted with the wild-type
RNA probe, but not with a mutant probe containing nucleotide
substitutions in the U-rich region. Interestingly, TIA-1 was found
to bind to the equivalent DNA T-rich probe, with a preference
for single-stranded rather than double-stranded DNA. The DNA
probe bound to TIA-1 with higher affinity than RNA yet, in
both cases, the major TIA-1 binding site was in the T/U-rich
region. Immunoprecipitation assays confirmed in vivo binding of
endogenous TIA-1 to COL2A1 genomic DNA and pre-mRNA.
Conclusions: This is the first report indicating TIA-1 as a reg-
ulator of COL2A1 alternative splicing. We also report a novel
function for TIA-1 by its ability to bind genomic DNA as well as
RNA. We suggest TIA-1 has a dual role in regulating COL2A1
expression by functioning at the level of transcription and pre-
mRNA splicing. TIA-1 is known to down-regulate expression
of the inflammatory mediators TNF-α and COX-2 by binding
adenylate/uridylate rich elements (AREs) in the 3’ untranslated
region of mRNA. These AREs contain repeats of the AUUUA
pentameric sequence also found in the COL2A1 cis element de-
scribed here. Since expression of the embryonic type IIA isoform
has been detected in osteoarthritic cartilage, TIA-1 may function
in promoting a tissue repair response by altering expression of
specific cartilage matrix protein isoforms in addition to repressing
inflammatory cytokine expression.
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F-SPONDIN, A NEURONAL DIFFERENTIATION FACTOR,
IS UPREGULATED IN OSTEOARTHRITIS: EVIDENCE FOR
REGULATION OF CHONDROCYTE METABOLISM VIA
LATENT TGF-B1 ACTIVATION
M. Attur, G. Palmer, H. Al-Mussawir, D. Rifkin, C. Teixeira,
F. Beier, S.B. Abramson
NYU Hospital for Joint Diseases, New York, NY
Purpose: F-spondin, first identified as a novel protein secreted
by neuronal cells, is a member of a family of proteins that collec-
tively belong to a subgroup of TSR (thrombospondin) type I class
molecules. We have discovered, using Affymetrix microarray
screening followed by confirmatory immunoblot and immunohis-
tochemistry, that F- spondin expression is significantly increased
in osteoarthritic cartilage. We here report studies designed to
elucidate its role.
Methods: Gene expression studies of cartilage from normal and
OA patients were performed using Affymetrix U95Av2 microarray.
The microarray data was normalized and analyzed using dchip
program. The differentially expressed gene was confirmed using
TaqMan Real Time PCR. Chondrocytes were isolated from OA
patients undergoing joint replacement surgery, using collagenase
digestion and cultured in monolayer. Prostaglandin E2 (PGE2),
was estimated using radioimmunoassay. The active and total
TGF-b1 was estimated using R&D systems ELISA kits.
Results: We studied the expression of F-spondin in 18 OA and
8 age-matched normal cartilage and synovium using Affymetrix
microarray. The OA specimens were obtained at the time of
joint replacement surgery and the normal tissues from acci-
dent victims. F-spondin was overexpressed in OA chondrocytes
(2-5 fold). The differential expression of F-spondin in cartilage
was confirmed by real time PCR and western blot. The expres-
sion of F-spondin in OA cartilage was also confirmed by im-
munostaining. F-spondin mRNA expression was also increased
in rat meniscectomy model of OA and expressed in hypertrophic
and calcified zones of chick embryonic growth plates. Unstimu-
lated chondrocytes constitutively expressed F-spondin, which de-
creased following exposure to IL-1 (10 ng/ml). In contrast, PGE2
(1-10 uM), significant increased F-spondin expression from 4-
48h following stimulation. This effect could be mimicked by the
cAMP analog, dibutyryl cAMP. Addition of F-spondin increased
PGE2 production in chondrocytes, which could be inhibited by
avb3 integrin blocking antibody LM609. Addition of growth fac-
tors FGF-basic, FGF-18 and TGF-b, enhanced the expression
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of F-spondin by 1.5 to 3 fold by 24h. Similarly, chondrocytes
exposed to retinol increased F-spondin expression by 2.5 fold
as compared to control cells. We next assessed the effects of
F-spondin on chondrocyte functions. Chondrocytes treated with
purified F-spondin exhibited increased expression of BMP2, type
II collagen, aggrecan and TGFB1. Finally, we hypothesized that
F-spondin, like thrombospondin, activates latent TGF-beta, since
both have conserved WSxW and KRFK motif sequence in TSR
domains, which are known to bind to latent TGF-b1 and release
active dimer TGF-b1. Unstimulated OA cartilage explants sponta-
neously released active TGFbeta1 (200pg/g cartilage) in culture
supernatants. The addition of recombinant F-spondin (R&D sys-
tems) increased the active TGF-b1 by 225% (550pg/g cartilage)
but not total (latent and active) TGF-b1.
Conclusions: These studies demonstrate that F-spondin is over-
expressed in OA cartilage. The data also suggest that one role
of F-spondin in OA is to upregulate anabolic factors, perhaps
indirectly via its capacity to activate latent TGF-b1.
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INTEGRIN αVβ5 MAY BE RESPONSIBLE FOR THE
SUPPRESSION OF CARTILAGE MATRIX GENES AND
FORMATION OF CYTOSKELETONS DURING
DEDIFFERENTIATION IN THE MONOLAYER CULTURED
ADULT HUMAN ARTICULAR CHONDROCYTES
N. Fukui1, Y. Ikeda1, T. Ohnuki1, N. Tanaka1, A. Hikita1,
S. Yamane1, R. Suzuki1, T. Ochi1, Y. Katsuragawa2,
S. Yamamoto3
1Clinical Resarch Center, National Hospital Organization
Sagamihara Hospital, Sagamihara, Kanagawa Prefecture,
Japan, 2International Medical Center of Japan, Tokyo, Japan,
3Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
Purpose: The purpose of this study was to elucidate the mech-
anism(s) involved in the dedifferentiation of monolayer cultured
adult human articular chondrocytes.
Methods: The study was performed under the approval of insti-
tutional review boards. Primary cultured articular chondorcytes
were obtained from human OA knee joints and cultured in mono-
layer. In the chondrocytes, the expression of integrins was sup-
pressed by RNAi. The siRNAs were introduced by electroporation
using a Nucleofector® (Amaxa), and suppression of integrin ex-
pression was confirmed by real-time PCR and flow cytometry.
The influence of suppressed integrin expression on the dediffer-
entiation process was assessed by the expression levels of type
II collagen and aggrecan as cartilage matrix genes, and type I
and type III collagen as aberrant genes induced with dediffer-
entiation. Morphological change of the cells was observed on a
light microscope, and formation of cytoskeleton and focal adhe-
sion was evaluated by fluorescent immunostaining on a confocal
laser microscope. These results were confirmed by use of a
novel synthetic inhibitor for integrins. Further, the significance of
FAK and Grb2 in the dedifferentiation was evaluated by RNAi
experiments, and the involvement of ERK-1/2 signaling was as-
sessed by Western blotting, RNAi experiments, and U1026, a
specific inhibitor for the signaling.
Results: The introduction of siRNA into primary cultured chon-
drocytes successfully reduced the expression of integrins at Day
3-6 as confirmed by real-time PCR and flow cytometry. While
the suppression of α1, α2, α10, or β3 integrin did not cause sig-
nificant change in the dedifferentiation process, the suppression
of integrin αv and β5 both significantly inhibited the decline of
cartilage matrix gene expression that occurred during the dedif-
ferentiation. Further, the suppression of these integrins inhibited
flattening of the chondrocytes in the process. Inhibition of stress
fiber arrangement and focal adhesion formation was confirmed
by confocal laser microscopy. Interestingly, the suppression of αv
or β5 integrins did not alter the induction of type I or type III col-
lagen during dedifferentiation. These results were recapitulated
by a synthetic inhibitor for αvβ5 integrin. The suppression of FAK
and Grb2 by RNAi caused similar changes in the dedifferentia-
tion process, suggesting that these proteins could play certain
roles in the loss of chondrogenic phenotype. The involvement of
ERK-1/2 in the decline of cartilage matrix gene expression was
demonstrated by gene silencing of ERK-1 and use of U0126.
Addition of the integrin inhibitor to the media reduced the level
of ERK-1/2 phosphorylation, suggesting that the suppression of
αvβ5 integrin could inhibit the decline of cartilage gene expres-
sion through the reduction of ERK signaling.
Conclusions: The result of this study has shown that αvβ5
integrin may be responsible for the suppression of cartilage ma-
trix genes during dedifferentiation via the activation of ERK-1/2
signaling. We previously reported that integrin α5β1 could be
responsible for the induction of type III collagen during dediffer-
entiation. Thus, it is assumed that these integrin heterodimers
may promote different aspects of dedifferentiation in monolayer
cultured chondrocytes.
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NOTCH PATHWAY IS INVOLVED IN MURINE ARTICULAR
CHONDROCYTE DEDIFFERENTIATION
F. Berenbaum1, M. Mahjoub2, C. Salvat2, C. Brou3, M. Corvol4,
J.-F. Savouret4, F. Rannou4, P. Bausero2
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Purpose: Differentiated chondrocytes maintain homeostasis by
synthesizing cartilage-specific matrix molecules. However, this
equilibrium is disrupted during degradative joint diseases such
as osteoarthritis (OA). Notch receptors are involved in alterna-
tive cell fate determination during invertebrate and vertebrate
development as well as in the adulthood. Notch genes encode
single-pass transmembrane (TM) receptors. Activation of Notch
pathway involves a proteolytic cleavage by a gamme-secretase-
like activity leading to the release of the intracellular domain of
Notch which translocates into the nucleus where it participates
in the transcriptional activation of target genes. The aim of this
study is to determine the Notch pathway behaviour in a ded-
ifferentiating context in immature murine articular chondrocyte
(iMAC).
Methods: iMAC were seeded at a density of 8x103 cells/cm2
and reached confluence by day 6-7. Cells at this stage (desig-
nated "P0") exhibited the typical chondrocyte morphology. Serial
subculturing of cells from P0 to P3 resulted in a flattened and
fibroblast-like morphology.
Results: Expression levels for type II collagen (measured by
q-RT- PCR and western blot) and aggrecan (measured by q-RT-
PCR) were high at P0, began to decrease at P1, and were
almost undetectable from P3 onward, confirming that monolayer
culturing resulted in a typical chondrocyte dedifferentiating pro-
cess. The expression of the chondrocyte differentiation marker
SOX-9 was present until P3. To show the participation of Notch
signalling in the dedifferentiating process, we looked at the vari-
ation of the repressor-type basic helix-loop-helix (bHLH) HES1
(Homologous of Enhancer of Split) mRNA expression, a major
Notch target gene. HES1 mRNA was significatively increased
in P0 iMACs as compared to uncultured seeded iMAC and this
induction extended at P1 and P2. We cultured iMACs in the
presence of a γ-secretase inhibitor DAPT which is known to bind
to the active site of presenilin in the γ-secretase complex and
thus to inhibit Notch activation. HES1 mRNA level was signifi-
cantly diminished in the presence of DAPT. Interestingly, iMACs
